Published online Feb 27, 2024. doi: 10.4240/wjgs.v16.i2.529
Peer-review started: October 7, 2023
First decision: November 12, 2023
Revised: November 26, 2023
Accepted: January 29, 2024
Article in press: January 29, 2024
Published online: February 27, 2024
Processing time: 140 Days and 23 Hours
Over 90% of rectal cancer patients develop low anterior resection syndrome (LARS) after sphincter-preserving resection. The current globally recognized evaluation method has many drawbacks and its subjectivity is too strong, which hinders the research and treatment of LARS.
To evaluate the anorectal function after colorectal cancer surgery by quantifying the index of magnetic resonance imaging (MRI) defecography, and pathogenesis of LARS.
We evaluated 34 patients using the standard LARS score, and a new LARS evaluation index was established using the dynamic images of MRI defecography to verify the LARS score.
In the LARS score model, there were 10 (29.41%) mild and 24 (70.58%) severe cases of LARS. The comparison of defecation rate between the two groups was 29.36 ± 14.17% versus 46.83 ± 18.62% (P = 0.004); and MRI-rectal compliance (MRI-RC) score was 3.63 ± 1.96 versus 7.0 ± 3.21 (P = 0.001). Severe and mild LARS had significant differences using the two evaluation methods. There was a significant negative correlation between LARS and MRI-RC score (P < 0.001), and they had a negative correlation with defecation rate (P = 0.028).
MRI defecography and standard LARS score can both be used as an evaluation index to study the pathogenesis of LARS.
Core Tip: Currently, the evaluation of low anterior resection syndrome (LARS) symptoms in patients is solely reliant on subjective measures, such as questionnaires. There is a lack of a standardized and objective medical assessment index. We innovatively used magnetic resonance imaging (MRI) defecography to judge and quantify the compliance of neorectum after rectal cancer surgery. We established the objective diagnosis and severity evaluation criteria for LARS MRI defecography, quantify the severity of LARS by objective clinical evaluation index, which promotes the exploration of the pathogenesis of LARS.